Rexipra-20 – Strip of 10 Tablets

Description

Product Name:

Rexipra-20

Pack Size:

Strip of 10 Film-Coated Tablets

Composition (Per Tablet):

• Active Ingredient:

  • Escitalopram Oxalate I.P.
    Equivalent to Escitalopram 20 mg

• Excipients:

  • q.s. (quantum satis) – used in required quantities to complete the formulation.

  • Common excipients in tablets may include:

    • Microcrystalline Cellulose (diluent)

    • Lactose Monohydrate (filler)

    • Magnesium Stearate (lubricant)

    • Colloidal Silicon Dioxide (glidant)

    • Talc (anti-caking agent)

    • Hypromellose (coating polymer)

    • Titanium Dioxide (colorant in coating)

    • Polyethylene Glycol (plasticizer)

Note: The exact excipients may vary slightly based on the manufacturer’s formulation and are not always disclosed on the strip or label.

Therapeutic Class:

Antidepressant (Selective Serotonin Reuptake Inhibitor – SSRI)

Indications (Uses):

• Major Depressive Disorder (MDD)

• Generalized Anxiety Disorder (GAD)

• Panic Disorder

• Social Anxiety Disorder

• Obsessive-Compulsive Disorder (OCD)
  (off-label in some cases)

Mechanism of Action:

Escitalopram selectively inhibits the reuptake of serotonin (5-HT) into the presynaptic neuron, increasing serotonin levels in the synaptic cleft. This helps improve mood and reduce anxiety symptoms.

Dosage:

• Typically 10 mg once daily, with or without food.

• Dose may be adjusted by a physician based on response (commonly up to 20 mg/day).

• Always follow your doctor’s prescription.

Common Side Effects:

• Nausea

• Headache

• Dry mouth

• Insomnia or drowsiness

• Dizziness

• Increased sweating

• Decreased libido or sexual dysfunction

Precautions:

• Avoid alcohol during treatment.

• Use with caution in patients with liver or kidney impairment.

• May increase the risk of suicidal thoughts in adolescents and young adults.

• Should not be stopped abruptly — tapering under medical guidance is essential.

Contraindications:

• Hypersensitivity to escitalopram or any component of the formulation

• Concurrent use with monoamine oxidase inhibitors (MAOIs)

Let me know if you want the same information for Rexipra-5 or Rexipra-10, or a patient-friendly summary in Hindi or another language.